CAR T-cell Therapy Market Advances Oncology Treatment
The global CAR T-cell therapy market size was estimated at USD 5.82 billion in 2025 and is projected to reach USD 22.36 billion by 2033, expanding at [read full press release…]
Immunotherapy
The Oncolytic Virus Immunotherapy Market To Witness Spillage Of Digitized Beans At A CAGR Of ~12%
New York, United States, 2022-May-31 — /EPR Network/ — The Oncolytic Virus Immunotherapy Market is expected to grow on a healthy note in the subsequent [read full press release…]
The next decade to see the Oncolytic Virus Immunotherapy Market climb digitally upwards at a CAGR of ~12%
New York, United States, 2022-May-03 — /EPR Network/ — The Oncolytic Virus Immunotherapy Market is expected to grow on a healthy note in the subsequent [read full press release…]
Pediatric Neuroblastoma Treatment Market Significant Profits Estimated to be Generated by 2026
Preference as a precautionary healthcare procedure for immunocompromised children continue to bolster the growth of pediatric neuroblastoma treatment market. reveals Fact.MR. High incidences of neuroblastoma [read full press release…]
Pediatric Neuroblastoma Treatment Market Growth Set to Surge Significantly during 2020 to 2026
Preference as a precautionary healthcare procedure for immunocompromised children continue to bolster the growth of pediatric neuroblastoma treatment market. reveals Fact.MR. High incidences of neuroblastoma [read full press release…]
Pediatric Neuroblastoma Treatment Market to Witness a Pronounce Growth During 2020 to 2026
Preference as a precautionary healthcare procedure for immunocompromised children continue to bolster the growth of pediatric neuroblastoma treatment market. reveals Fact.MR. High incidences of neuroblastoma [read full press release…]
Pediatric Neuroblastoma Treatment Market Show Exponential Growth by 2026
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Pediatric Neuroblastoma Treatment market during the historical period of 2014 – [read full press release…]
Pediatric Neuroblastoma Treatment Market to Record an Exponential CAGR by 2026
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Pediatric Neuroblastoma Treatment market during the historical period of 2014 – [read full press release…]
Explore the novel trends in Cancer at Cancer Therapy Meeting 2018
LONDON, United Kingdom, 2018-Jun-25 — /EPR Network/ — ConferenceSeries llc LTD, host of Experts Meet on Cancer Therapy 2018, the Conference that discusses the Advanced trends for [read full press release…]
Cancer Immunotherapies – First-in-Class Pipeline Dominated by Immunomodulators and PD-1 like Targets – Pharmaceuticals Market Reports
Albany, US, 2017-Oct-09 — /EPR Network/ — The presented report on Cancer Immunotherapies is replete with detailed analysis from a thorough research, especially on questions that [read full press release…]
Global Indoleamine 2, 3 Dioxygenase 1 Industry Vital Pipeline Review for the First Half of 2017
Albany, New York, 2017-Jul-05 — /EPR Network/ — The indoleamine 2, 3 Dioxygenase 1 or IDO1 market is developing since the cancer treatment sector relies [read full press release…]
Aminopeptidase N (Myeloid Plasma Membrane Glycoprotein CD13 or Alanyl Aminopeptidase) Pipeline Landscape and Therapeutic Assessment in H1 2017
Albany, New York, 2017-Jul-05 — /EPR Network/ — According to the latest pipeline analysis, Aminopeptidase N (APN/CD13) acts as an exopeptidase and has been studied for [read full press release…]
Celdara Medical Receives $2M Phase II SBIR Grant
Lebanon, NH, 2017-Jun-19 — /EPR Network/ — Celdara Medical, LLC today announced that the National Cancer Institute of the National Institutes of Health has awarded a [read full press release…]
